HLMRX
Price
$16.17
Change
+$0.46 (+2.93%)
Updated
Apr 9 closing price
Net Assets
333.33M
OSMNX
Price
$33.38
Change
+$1.68 (+5.30%)
Updated
Apr 9 closing price
Net Assets
3.09B
Ad is loading...

HLMRX vs OSMNX

Header iconHLMRX vs OSMNX Comparison
Open Charts HLMRX vs OSMNXBanner chart's image
Harding Loevner Intl Small Coms Instl
Price$16.17
Change+$0.46 (+2.93%)
VolumeN/A
Net Assets333.33M
Invesco International Small-Mid Com R
Price$33.38
Change+$1.68 (+5.30%)
VolumeN/A
Net Assets3.09B
HLMRX vs OSMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLMRX vs. OSMNX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLMRX is a Hold and OSMNX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
OSMNX has more cash in the bank: 3.09B vs. HLMRX (333M). HLMRX pays higher dividends than OSMNX: HLMRX (1.30) vs OSMNX (1.19). HLMRX was incepted earlier than OSMNX: HLMRX (14 years) vs OSMNX (24 years). OSMNX (1.63) is less costly to investors than HLMRX (1.16). OSMNX is a more actively managed with annual turnover of: 21.00 vs. HLMRX (17.00). OSMNX has a lower initial minimum investment than HLMRX: OSMNX (1000) vs HLMRX (100000). HLMRX annual gain was more profitable for investors over the last year : -11.92 vs. OSMNX (-18.89). HLMRX return over 5 years is better than : 22.30 vs. OSMNX (-13.82).
HLMRXOSMNXHLMRX / OSMNX
Total Expense Ratio1.151.6371%
Annual Report Gross Expense Ratio1.161.6371%
Fund Existence14 years24 years-
Gain YTD-6.434-5.638114%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets333M3.09B11%
Annual Yield % from dividends1.301.19108%
Returns for 1 year-11.92-18.8963%
Returns for 3 years-14.81-25.5558%
Returns for 5 years22.30-13.82-161%
Returns for 10 years17.49-4.73-370%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGICX62.40N/A
N/A
JPMorgan US Value C
RTOUX33.90N/A
N/A
Russell Inv Tax-Managed US Mid&Sm Cap M
FAPMX11.68N/A
N/A
Fidelity Advisor Healthy Future I
HIEMX6.83N/A
N/A
Virtus SGA Emerging Markets Equity I
PMGJX6.09N/A
N/A
Principal MidCap Growth J